NO171593C - Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav - Google Patents

Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav

Info

Publication number: NO171593C
Authority: NO; Norway
Prior art keywords: preparation; hydrated; procedure; crystalline calcium; calcium pseudomonate
Prior art date: 1984-06-19

Application number

NO852446A

Other languages

English (en)

Norwegian (no)

Other versions

NO852446L (no

NO171593B (no

Inventor

Geoffrey Harold Baker

Merle Beal

Original Assignee

Beecham Group Plc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1984-06-19

Filing date

1985-06-17

Publication date

1993-04-07

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=10562629&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO171593(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

1985-06-17 Application filed by Beecham Group Plc filed Critical Beecham Group Plc

1985-12-20 Publication of NO852446L publication Critical patent/NO852446L/no

1992-12-28 Publication of NO171593B publication Critical patent/NO171593B/no

1993-04-07 Publication of NO171593C publication Critical patent/NO171593C/no

Links

DDHVILIIHBIMQU-YJGQQKNPSA-L mupirocin calcium hydrate Chemical compound O.O.[Ca+2].C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1.C[C@H](O)[C@H](C)[C@@H]1O[C@H]1C[C@@H]1[C@@H](O)[C@@H](O)[C@H](C\C(C)=C\C(=O)OCCCCCCCCC([O-])=O)OC1 DDHVILIIHBIMQU-YJGQQKNPSA-L 0.000 title abstract 2
241001465754 Metazoa Species 0.000 abstract 1
150000004683 dihydrates Chemical class 0.000 abstract 1
239000003814 drug Substances 0.000 abstract 1
239000007952 growth promoter Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K50/00—Feeding-stuffs specially adapted for particular animals
- A23K50/30—Feeding-stuffs specially adapted for particular animals for swines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Life Sciences & Earth Sciences (AREA)
Polymers & Plastics (AREA)
Health & Medical Sciences (AREA)
Engineering & Computer Science (AREA)
Food Science & Technology (AREA)
Zoology (AREA)
Animal Husbandry (AREA)
General Health & Medical Sciences (AREA)
General Chemical & Material Sciences (AREA)
Animal Behavior & Ethology (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Chemical Kinetics & Catalysis (AREA)
Birds (AREA)
Obesity (AREA)
Hematology (AREA)
Diabetes (AREA)
Oncology (AREA)
Communicable Diseases (AREA)
Bioinformatics & Cheminformatics (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Steroid Compounds (AREA)
Compounds Of Alkaline-Earth Elements, Aluminum Or Rare-Earth Metals (AREA)
Preparation Of Compounds By Using Micro-Organisms (AREA)
Fodder In General (AREA)
Diaphragms For Electromechanical Transducers (AREA)
Crystals, And After-Treatments Of Crystals (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Coloring Foods And Improving Nutritive Qualities (AREA)
Electroluminescent Light Sources (AREA)
Plural Heterocyclic Compounds (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Liquid Crystal Substances (AREA)
Cosmetics (AREA)

NO852446A 1984-06-19 1985-06-17 Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav NO171593C (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
GB848415579A GB8415579D0 (en)	1984-06-19	1984-06-19	Compounds

Publications (3)

Publication Number	Publication Date
NO852446L NO852446L (no)	1985-12-20
NO171593B NO171593B (no)	1992-12-28
NO171593C true NO171593C (no)	1993-04-07

Family

ID=10562629

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO852446A NO171593C (no)	1984-06-19	1985-06-17	Fremgangsmaate for fremstilling av krystallinsk kalsium-pseudomonat eller et hydrat derav

Country Status (27)

Country	Link
US (5)	US4916155A (de)
EP (1)	EP0167856B1 (de)
JP (1)	JPH0723373B2 (de)
KR (1)	KR930002509B1 (de)
AT (1)	ATE49600T1 (de)
AU (1)	AU577595B2 (de)
CA (1)	CA1242437A (de)
DE (1)	DE3575428D1 (de)
DK (1)	DK164506C (de)
ES (1)	ES8604249A1 (de)
FI (2)	FI84179C (de)
GB (1)	GB8415579D0 (de)
GR (1)	GR851470B (de)
HU (1)	HU195515B (de)
IE (1)	IE58118B1 (de)
IL (1)	IL75536A (de)
JO (1)	JO1420B1 (de)
MX (1)	MX163401B (de)
MY (1)	MY102549A (de)
NO (1)	NO171593C (de)
NZ (1)	NZ212433A (de)
PH (1)	PH22951A (de)
PL (1)	PL254033A1 (de)
PT (1)	PT80657B (de)
YU (1)	YU45724B (de)
ZA (1)	ZA854549B (de)
ZM (1)	ZM4185A1 (de)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8415579D0 (en) *	1984-06-19	1984-07-25	Beecham Group Plc	Compounds
GB8530796D0 (en) *	1985-12-13	1986-01-22	Beecham Group Plc	Pharmaceutical composition
IE59628B1 (en) *	1986-06-26	1994-03-09	Beecham Group Plc	Treatment of fungal infections
US5273998A (en) *	1990-05-11	1993-12-28	Yoshitomi Pharmaceutical Industries, Ltd.	Process for making an optically active 3,4-dihydro-3,4-epoxy-2H-1-benzopyran compound
GB9507825D0 (en) *	1995-04-18	1995-05-31	Wet Pieter M De	Method of treatment
GB9616208D0 (en)	1996-08-01	1996-09-11	Smithkline Beecham Plc	Novel Compounds
JP2001504091A (ja) *	1996-10-01	2001-03-27	スミスクライン・ビーチャム・コーポレイション	病原性生物による鼻咽腔のコロニー形成に関連する細菌感染の治療のための薬剤の製造のためのミュピロシンの使用
CO4910145A1 (es)	1996-10-01	2000-04-24	Smithkline Beecham Corp	Uso
GB9808470D0 (en)	1998-04-22	1998-06-17	Smithkline Beecham Plc	Novel process and apparatus
CN1670217A (zh) *	1999-02-03	2005-09-21	特瓦药厂有限公司	经微生物学方法制备假单胞菌酸a抗生素的方法
HUP0500797A2 (en) *	2001-06-21	2007-06-28	Biogal Gyogyszergyar	Metabolic controlled fermentation process for pseudomonic acid production
EP1455769A4 (de)	2001-12-28	2004-09-22	Biogal Gyogyszergyar	Verfahren zur herstellung von kristallinem und amorphem mupirocin-calcium
IL150907A (en) *	2002-07-25	2007-07-04	Stephan Cherkez	Process for the preparation of stable amorphous calcium pseudomonate
WO2005009336A2 (en) *	2003-05-01	2005-02-03	Replidyne, Inc.	Antibacterial methods and compositions
ATE458476T1 (de) *	2004-06-01	2010-03-15	Teva Gyogyszergyar Zartkoeruen	Verfahren für die zubereitung der amorphen form eines medikamentes
JP5101305B2 (ja) *	2005-02-21	2012-12-19	シンジェンバイオテックカンパニーリミテッド	ムピロシン精製法
WO2006117762A2 (en)	2005-05-03	2006-11-09	Ranbaxy Laboratories Limited	Antimicrobial agents
EP1752516A1 (de) *	2005-08-01	2007-02-14	The Lubrizol Corporation	Dispergatoren
GB2441328A (en) *	2006-08-30	2008-03-05	Alpharma Aps	A method for obtaining mupirocin calcium
WO2009092991A1 (en) *	2008-01-24	2009-07-30	Pliva Hrvatska D.O.O.	Process for preparing crystalline calcium mupirocin dihydrate
WO2010132833A1 (en) *	2009-05-14	2010-11-18	The Regents Of The University Of Michigan	Streptococcus vaccine compositions and methods of using the same
WO2012014109A1 (en)	2010-07-30	2012-02-02	Ranbaxy Laboratories Limited	Heterocyclic sulfonamides as inhibitors of transfer rna synthetase for use as antibacterial agents
WO2016133471A1 (en)	2015-02-20	2016-08-25	Pharmacti̇ve İlaç Sanayi̇ Ve Ti̇caret A. Ş.	A topical composition comprising mupirocin and dexpanthenol
KR102101297B1 (ko)	2019-02-15	2020-05-26	주식회사 드림테크	급속 스팀 세척기 제어방법
KR102269617B1 (ko)	2020-10-27	2021-06-24	신현호	스팀 급속제조장치 및 그 제어방법

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4071536A (en) *	1971-06-12	1978-01-31	Beecham Group Limited	Antibiotics
GB1395907A (en) *	1971-06-12	1975-05-29	Beecham Group Ltd	Antibiotics
GB1587058A (en) *	1976-06-15	1981-03-25	Beecham Group Ltd	Oxiranylmethyltetrahydropyran derivatives
GB1577730A (en) *	1976-10-23	1980-10-29	Beecham Group Ltd	Treatment of infections with pseudomonicacid salts or esters thereof
GB1577545A (en) *	1977-07-27	1980-10-22	Beecham Group Ltd	Treatment of swine dysenter
CA1115699A (en) *	1978-05-20	1982-01-05	Alan D. Curzons	Lithium pseudomonate and its preparation
GB2097670B (en) *	1981-03-11	1985-02-27	Beecham Group Ltd	Growth promotor containing pseudomonic acid
GB8313035D0 (en) *	1983-05-12	1983-06-15	Beecham Group Plc	Compound
GB8415579D0 (en) *	1984-06-19	1984-07-25	Beecham Group Plc	Compounds
US4892960A (en) *	1985-01-28	1990-01-09	International Minerals & Chemical Corp.	Crystalline lysocellin compositions and method of making

1984
- 1984-06-19 GB GB848415579A patent/GB8415579D0/en active Pending
1985
- 1985-06-11 EP EP85107163A patent/EP0167856B1/de not_active Expired - Lifetime
- 1985-06-11 AT AT85107163T patent/ATE49600T1/de not_active IP Right Cessation
- 1985-06-11 DE DE8585107163T patent/DE3575428D1/de not_active Expired - Lifetime
- 1985-06-16 JO JO19851420A patent/JO1420B1/en active
- 1985-06-17 FI FI852407A patent/FI84179C/fi not_active IP Right Cessation
- 1985-06-17 ZM ZM41/85A patent/ZM4185A1/xx unknown
- 1985-06-17 ZA ZA854549A patent/ZA854549B/xx unknown
- 1985-06-17 YU YU101385A patent/YU45724B/sh unknown
- 1985-06-17 GR GR851470A patent/GR851470B/el unknown
- 1985-06-17 CA CA000484212A patent/CA1242437A/en not_active Expired
- 1985-06-17 PL PL25403385A patent/PL254033A1/xx unknown
- 1985-06-17 IE IE150685A patent/IE58118B1/en not_active IP Right Cessation
- 1985-06-17 NZ NZ212433A patent/NZ212433A/xx unknown
- 1985-06-17 AU AU43734/85A patent/AU577595B2/en not_active Expired
- 1985-06-17 NO NO852446A patent/NO171593C/no unknown
- 1985-06-17 IL IL75536A patent/IL75536A/xx not_active IP Right Cessation
- 1985-06-17 HU HU852380A patent/HU195515B/hu unknown
- 1985-06-18 PT PT80657A patent/PT80657B/pt unknown
- 1985-06-18 MX MX6897A patent/MX163401B/es unknown
- 1985-06-18 ES ES544329A patent/ES8604249A1/es not_active Expired
- 1985-06-18 JP JP60130963A patent/JPH0723373B2/ja not_active Expired - Lifetime
- 1985-06-18 KR KR1019850004305A patent/KR930002509B1/ko not_active Expired - Lifetime
- 1985-06-18 DK DK275585A patent/DK164506C/da not_active IP Right Cessation
- 1985-06-19 PH PH32428A patent/PH22951A/en unknown
1987
- 1987-09-21 MY MYPI87001798A patent/MY102549A/en unknown
1989
- 1989-04-13 US US07/338,446 patent/US4916155A/en not_active Expired - Lifetime
1990
- 1990-03-12 US US07/468,584 patent/US5191093A/en not_active Expired - Lifetime
1991
- 1991-07-04 FI FI913260A patent/FI88796C/fi not_active IP Right Cessation
1994
- 1994-02-28 US US08/203,681 patent/US5436266A/en not_active Expired - Lifetime
1995
- 1995-05-09 US US08/437,357 patent/US5569672A/en not_active Expired - Lifetime
- 1995-05-09 US US08/437,359 patent/US5792790A/en not_active Expired - Lifetime

Also Published As

Publication number	Publication date
EP0167856A3 (en)	1986-11-26
IE58118B1 (en)	1993-07-14
KR860000291A (ko)	1986-01-27
DK164506B (da)	1992-07-06
FI913260A0 (fi)	1991-07-04
HUT38654A (en)	1986-06-30
JPH0723373B2 (ja)	1995-03-15
ZM4185A1 (en)	1985-11-22
DK275585D0 (da)	1985-06-18
MY102549A (en)	1992-07-31
KR930002509B1 (ko)	1993-04-03
US5569672A (en)	1996-10-29
CA1242437A (en)	1988-09-27
MX163401B (es)	1992-05-11
ES8604249A1 (es)	1986-01-16
US4916155A (en)	1990-04-10
GB8415579D0 (en)	1984-07-25
YU101385A (en)	1988-02-29
FI852407A0 (fi)	1985-06-17
YU45724B (sh)	1992-07-20
AU577595B2 (en)	1988-09-29
NZ212433A (en)	1988-08-30
PH22951A (en)	1989-02-03
NO852446L (no)	1985-12-20
DE3575428D1 (de)	1990-02-22
HU195515B (en)	1988-05-30
ATE49600T1 (de)	1990-02-15
DK275585A (da)	1985-12-20
ZA854549B (en)	1986-05-28
EP0167856B1 (de)	1990-01-17
NO171593B (no)	1992-12-28
US5191093A (en)	1993-03-02
FI88796B (fi)	1993-03-31
PL254033A1 (en)	1986-04-22
JPS6117583A (ja)	1986-01-25
IE851506L (en)	1985-12-19
IL75536A0 (en)	1986-01-31
GR851470B (de)	1985-11-25
US5792790A (en)	1998-08-11
AU4373485A (en)	1986-01-02
US5436266A (en)	1995-07-25
FI852407L (fi)	1985-12-20
FI88796C (fi)	1993-07-12
FI84179C (fi)	1991-10-25
IL75536A (en)	1989-01-31
DK164506C (da)	1992-11-23
JO1420B1 (en)	1986-11-30
PT80657B (en)	1987-05-04
ES544329A0 (es)	1986-01-16
FI84179B (fi)	1991-07-15
PT80657A (en)	1985-07-01
EP0167856A2 (de)	1986-01-15

Publication	Publication Date	Title
AU577595B2 (en)	1988-09-29	Crystalline calcium pseudomonate
ATE126433T1 (de)	1995-09-15	Verwendung von gamma-hydroxy-buttersäuresalzen zur herstellung von pharmazeutischen zusammensetzungen zur verwendung bei der behandlung von alkoholismus und die hergestellten zusammensetzungen.
ATE110745T1 (de)	1994-09-15	Wachstumshormonkristalle und verfahren zu deren herstellung.
ATE84716T1 (de)	1993-02-15	4-chinolincarbonsaeure-derivate, brauchbar zur behandlung von haut- und muco-epithelialgewebekrankheiten.
BE895961A (fr)	1983-06-16	Procede de preparation d'un clone bacterien produisant de 1'alpha 1-antitrypsine humaine
DE58903876D1 (de)	1993-04-29	Riboflavin-4'5'-cyclo-phosphorsaeureesterchlorid, dessen herstellung und verwendung zur herstellung von riboflavin-5'-phosphat (5'-fmn) bzw. dessen natriumsalz.
NO893256D0 (no)	1989-08-14	Fremgangsmaate for fremstilling av furyltiazolderivater.
IL84889A0 (en)	1988-06-30	Salts of pyrophosphorous acid,their preparation and their use as microbicides
IT8323135A0 (it)	1983-10-04	Procedimento per produrre cuoio artificiale permeabile all'umidita'.
ATA188385A (de)	1990-07-15	Verwendung von peroxydiphosphaten zur herstellung von pharmazeutischen tabletten bzw. pharmazeutischen waesserigen loesungen
DE3689562D1 (de)	1994-03-03	Verfahren zur Erzeugung des menschlichen Wachstumhormons.
DK268487D0 (da)	1987-05-26	Alkoxyalkyl- og alkylmercaptoalkylsubstituerede, bicycliske benzofuroisoquinoliner eller syreadditionssalte deraf og deres anvendelse
ATE87309T1 (de)	1993-04-15	Azol-derivate verwendbar zur kontrolle von pflanzenkrankheiten und regulierung von pflanzenwachstum.
IT8848237A0 (it)	1988-07-27	Procedimento per la produzione difosfati cristallini di titanio, di zirconio e misti di zirconio e titanio
MX156014A (es)	1988-06-16	Procedimiento para preparar la sal de calcio del acido beta(4,5-difenil-oxasol-2-il) propionico
ES512680A0 (es)	1983-02-16	Procedimiento de preparacion de la sal de calcio del acido 2,5-dihidroxibencenosulfonico.